Materials Map

Discover the materials research landscape. Find experts, partners, networks.

  • About
  • Privacy Policy
  • Legal Notice
  • Contact

The Materials Map is an open tool for improving networking and interdisciplinary exchange within materials research. It enables cross-database search for cooperation and network partners and discovering of the research landscape.

The dashboard provides detailed information about the selected scientist, e.g. publications. The dashboard can be filtered and shows the relationship to co-authors in different diagrams. In addition, a link is provided to find contact information.

×

Materials Map under construction

The Materials Map is still under development. In its current state, it is only based on one single data source and, thus, incomplete and contains duplicates. We are working on incorporating new open data sources like ORCID to improve the quality and the timeliness of our data. We will update Materials Map as soon as possible and kindly ask for your patience.

To Graph

1.080 Topics available

To Map

977 Locations available

693.932 PEOPLE
693.932 People People

693.932 People

Show results for 693.932 people that are selected by your search filters.

←

Page 1 of 27758

→
←

Page 1 of 0

→
PeopleLocationsStatistics
Naji, M.
  • 2
  • 13
  • 3
  • 2025
Motta, Antonella
  • 8
  • 52
  • 159
  • 2025
Aletan, Dirar
  • 1
  • 1
  • 0
  • 2025
Mohamed, Tarek
  • 1
  • 7
  • 2
  • 2025
Ertürk, Emre
  • 2
  • 3
  • 0
  • 2025
Taccardi, Nicola
  • 9
  • 81
  • 75
  • 2025
Kononenko, Denys
  • 1
  • 8
  • 2
  • 2025
Petrov, R. H.Madrid
  • 46
  • 125
  • 1k
  • 2025
Alshaaer, MazenBrussels
  • 17
  • 31
  • 172
  • 2025
Bih, L.
  • 15
  • 44
  • 145
  • 2025
Casati, R.
  • 31
  • 86
  • 661
  • 2025
Muller, Hermance
  • 1
  • 11
  • 0
  • 2025
Kočí, JanPrague
  • 28
  • 34
  • 209
  • 2025
Šuljagić, Marija
  • 10
  • 33
  • 43
  • 2025
Kalteremidou, Kalliopi-ArtemiBrussels
  • 14
  • 22
  • 158
  • 2025
Azam, Siraj
  • 1
  • 3
  • 2
  • 2025
Ospanova, Alyiya
  • 1
  • 6
  • 0
  • 2025
Blanpain, Bart
  • 568
  • 653
  • 13k
  • 2025
Ali, M. A.
  • 7
  • 75
  • 187
  • 2025
Popa, V.
  • 5
  • 12
  • 45
  • 2025
Rančić, M.
  • 2
  • 13
  • 0
  • 2025
Ollier, Nadège
  • 28
  • 75
  • 239
  • 2025
Azevedo, Nuno Monteiro
  • 4
  • 8
  • 25
  • 2025
Landes, Michael
  • 1
  • 9
  • 2
  • 2025
Rignanese, Gian-Marco
  • 15
  • 98
  • 805
  • 2025

Petersen, Marta Axelstad

  • Google
  • 3
  • 6
  • 76

in Cooperation with on an Cooperation-Score of 37%

Topics

Publications (3/3 displayed)

  • 2013Triclosan exposure reduces thyroxine levels in pregnant and lactating rat dams and in directly exposed offspring76citations
  • 2007In vitro and in vivo screening of azole fungicides for antiandrogenic effectscitations
  • 2006In vitro screening of azole fungicides for antiandrogenic effects – comparison with in vivo effectscitations

Places of action

Chart of shared publication
Hass, Ulla
3 / 5 shared
Vinggaard, Anne Marie
3 / 6 shared
Boberg, Julie
1 / 2 shared
Christiansen, Sofie
1 / 4 shared
Nellemann, Christine
1 / 1 shared
Taxvig, Camilla
2 / 5 shared
Chart of publication period
2013
2007
2006

Co-Authors (by relevance)

  • Hass, Ulla
  • Vinggaard, Anne Marie
  • Boberg, Julie
  • Christiansen, Sofie
  • Nellemann, Christine
  • Taxvig, Camilla
OrganizationsLocationPeople

document

In vitro and in vivo screening of azole fungicides for antiandrogenic effects

  • Hass, Ulla
  • Petersen, Marta Axelstad
  • Vinggaard, Anne Marie
  • Nellemann, Christine
  • Taxvig, Camilla
Abstract

In general, azole fungicides have a low acute toxicity, but we have only little knowledge about their potential health risks at low chronic exposures. Previously we have shown that prochloraz has multiple potential mechanisms of action in cell-based assays, and prochloraz possessed antiestrogenic and antiandrogenic effects both in vitro and in vivo. Two other azole fungicides, tebuconazole and epoxiconazole, have now been investigated for antiandrogenic effects in vitro and in vivo as well. The fungicides were screened in two well-established cell assays, including testing for agonistic and antagonistic effects on AR in transfected CHO cells, using an AR reporter gene assay. The compounds were also analyzed for effects on steroidogenesis in H295R cells, a human adrenocorticocarcinoma cell line, used to detect effects on steroid production. In vitro tebuconazole and epoxiconazole proved to be antagonists of the AR, and in the H295R cell assay, they were able to inhibit testosterone and estradiol levels, and increase progesterone levels.In an in vivo study, designed to test for developmental effects on rat offspring after prenatal exposure, the effects on hormone levels in male fetuses and morphological signs of feminization of the male offspring were investigated. Tebuconazole caused an increase in testicular 17alfa-hydroxyprogesterone and progesterone levels, and a decrease in testosterone levels in male fetuses. Epoxiconazole had no effect on any of the mesured hormonelevels. Furthermore, tebuconazole increased the AGD in female pups and resulted in an increased number of nipples in male pups, a tendency that was also seen for epoxiconazole, though it was not statistically significant.In conclusion the results obtained in vitro are in good agreement with the effects observed in vivo. Tebuconazole showed antiandrogenic effects both in vitro and in vivo. Antiandrogenic effects were also seen for epoxiconazole in vitro, however the dominating effect observed in vivo was a high frequency of stillbirths at the highest dose.

Topics
  • compound
  • toxicity